Filing Details
- Accession Number:
- 0000950170-24-106413
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-13 16:47:50
- Reporting Period:
- 2024-09-11
- Accepted Time:
- 2024-09-13 16:47:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1719714 | Mereo Biopharma Group Plc | MREO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2005875 | Alexandra Hughes-Wilson | C/O Mereo Biopharma Group Plc 4Th Floor, One Cavendish Place London X0 W1G 0QF | See Remarks | No | No | No | No |
Transaction Summary
Number of Shares After Transactions: | 242,881 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-09-11 | 40,000 | $0.00 | 74,548 | No | 4 | M | Direct | |
American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-09-11 | 93,333 | $1.40 | 167,881 | No | 4 | M | Direct | |
American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-09-11 | 75,000 | $1.01 | 242,881 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
American Depository Shares | Performance Based Restricted Stock Unit | Disposition | 2024-09-11 | 40,000 | $0.00 | 40,000 | $0.00 |
American Depository Shares | Share Options (Right to buy) | Disposition | 2024-09-11 | 93,333 | $1.40 | 93,333 | $1.40 |
American Depository Shares | Share Options (Right to buy) | Disposition | 2024-09-11 | 75,000 | $1.01 | 75,000 | $1.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-09-11 | 2025-01-25 | No | 4 | M | Direct |
0 | 2032-01-14 | No | 4 | M | Direct | |
0 | 2033-01-25 | No | 4 | M | Direct |
Footnotes
- Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
- Represents performance-based restricted stock unit earned under the issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on September 11, 2024 based on satisfaction of ADS price threshold values over a two year performance period.
- 160,000 options were issued on 01/14/2022 and 25% of the shares underlying this award became exercisable on January 14, 2023, with the remainder vesting in equal monthly installments thereafter.
- 240,000 options were issued on 01/25/2023 and 25% of the shares underlying this award became exercisable on January 25, 2024, with the remainder vesting in equal monthly installments thereafter.